Bibliografía del artículo
1. Gregory L, Burke MD, Alain G Bertoni AG, et al. The impact of obesity on cardiovascular disease. Risk factors and subclinical vascular disease. The multy ethnic study of artherosclerosis. Archiv Intern Medic 168(9):928-935, 2008.
2. Nawcroki AR, Scheer PE. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Cur Opin Pharmacol 4:281-289, 2004.
3. Shibata R, Ouchi N, Ito M, kihara S, Shiojima I, et al. Adiponectin-mediated modulation of hypertrophic signal in the heart. Nat Med 10:1384-89, 2004.
4. Valdes Quintana EF. Síndrome metabólico y riesgo cardiovascular. Acta Cardiol Arg 2:7-10, 2005.
5. Esposito K, Pomtillo A, Di Paolo C, Giugliano G, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. A randomized trial. JAMA 289:1799-1804, 2003.
6. Tooth PP. High-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects. Dis Mon 47(8):369-416, 2001.
7. Ginsberg HN. New perspective on atherogenesis. Role of abnormal triglyceride-rich lipoprotein metabolism. Circulation 106:2137-42, 2002.
8. Kralisch S, Sommer G, Decker CM, Linke A, et al. Adipokines in diabetes and cardiovascular disease. Endocrinol Minerva 32(3):161-71, 2007.
9. Tooth P. High-density lipoprotein and cardiovascular risk. Circulation 109:1809-1812, 2004.
10. Tooth PP. Adiponectin and high-density lipoprotein: a metabolic association through thick and thin. Europ Heart J 26(16):1579-81, 2005.
11. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J.Clin Endocrinol Metabol 89:2548-56, 2004.
12. Yamauchi T, Kamon J, Waki H, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001.
13. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. Adiponectin stimulate glucose utilization and fatty-acid oxidation by activating AMP-activated proteinkinase. Nat Med 8:1288-1295, 2002.
14. Kumada M, Kithara S, Sumitsuji S, Kawamoto, Matsumoto S, et al. CAD Study Group. Association of hipoadiponectinemia with coronary artery disease in men. Arteroscl Tromb Vasc Biol 23:85-89, 2003.
15. Rothenbacher D, Brenner H, Marz W, Koening W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26:1640-46, 2005.
16. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737, 2004.